
Jakob Emerson on ACA Subsidies, Medicare Advantage and What Q2 Earnings Reveal
Becker’s Healthcare PodcastSummary
The expiration of enhanced Affordable Care Act (ACA) subsidies at the end of last year has created significant financial implications for both health insurers and hospitals. While insurers have managed to navigate the fallout better than expected, hospitals are facing a surge in uninsured patients, which is impacting their margins. Major health systems like HCA and Tenet have reported mixed results, with some seeing solid earnings despite the challenges posed by the loss of ACA coverage.
Insurers, particularly those in the Medicare Advantage sector, are experiencing a recovery in margins after a difficult period. Companies like Centene have reported substantial profits, partly due to strategic adjustments made in anticipation of the subsidy expiration. This trend reflects a broader shift among payers, who are now focusing on margin recovery and targeted exits from less profitable markets, contrasting with the previous decade's growth-at-all-costs mentality.
As hospitals grapple with the financial strain of increased uninsured patient volumes, they are also facing tougher negotiations with Medicare Advantage plans over reimbursement policies. This dynamic is leading to heightened tensions between health systems and insurers, as hospitals seek to secure fair compensation for the care they provide. Overall, while the landscape remains challenging, both payers and providers are adapting to the new realities of the healthcare market.
Show Notes
In this episode, Jakob Emerson, Associate News Director, Becker’s Healthcare, breaks down the latest hospital and payer earnings, examining how expiring ACA subsidies, Medicare Advantage margin recovery, and shifting reimbursement dynamics are reshaping financial performance and strategy across the healthcare industry.
More from Becker’s Healthcare Podcast
In this episode, Matt Davis, Zone Leader of Hospital Patient Monitoring, Philips North America, and Adam Alkhato, Senior Director, Biomedical Engineering & Life Science Technology, Stanford Health Care, discuss how health systems can build a strong foundation for clinical AI through bedside data integration, high-value use cases, measurable ROI and effective governance.
In this episode, Dr. Michael Bass, Global Medical Director, Viome, discusses how microbiome testing and personalized nutrition can help clinicians address persistent GI symptoms, improve clinical decision making, and support earlier pancreatic cancer detection. He also explores emerging trends in AI, preventative care, and the future of clinical practice.
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Chris Carmody, Chief Technology Officer, UPMC, who discusses using AI to turn growing volumes of healthcare data into actionable clinical insights, reduce fragmentation and create a more seamless experience across care settings.
In this episode, Dr. Patricia Henwood, EVP, Chief Clinical Officer at Jefferson Health, discusses the health system’s approach to AI integration, including its intent, integration, and impact framework, ambient AI results, and patient facing AI voice agents designed to improve care access, clinician efficiency, and patient experience.
Andy Colbert, Senior Managing Director at Ziegler, discusses the forces shaping ASC ownership and transactions in 2027, including joint ventures, private equity investment, and physician alignment. He also covers deal structure, succession planning, rising operating costs, and developing the next generation of physician leaders.